ArticleMaterials today. Bio2026

From neuroinflammation to immune reprogramming: Nanozyme-Integrated nanoplatforms for neuroimmune modulation in Parkinson's disease.

Shu Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.